Breaking: UK expert panel says 'no' to routine PSA screening. Issue moves on to health ministries for final decisions., by @journotwit https://t.co/a0bYrG0wKW
'A Plea To All Doctors (from a doctor with cancer): Five lessons on bedside manner I would love my colleagues to learn,' Dr. Hannah Harris, by @journotwit https://t.co/27piNagXXY
Part 2. Low T, low-risk prostate cancer. Safe to treat with testosterone. But new indications low T poses risk for cancer progression https://t.co/zwtjC2byK2
Part 2. Low T, low-risk prostate cancer. Safe to treat with testosterone. But new indications low T poses risk for cancer progression https://t.co/zwtjC2byK2
Prostate cancer in 2026 will surpass breast cancer for the first time in years, American Cancer Society forecasts, by @journotwit https://t.co/FAz2A8W9MT
Do an estimated 2k American deaths/year from prostate biopsy stand up against new study showing zero deaths in a 30-year study of prostate biopsy malpractice suits?, by @journotwit https://t.co/56qtS6OvEg
Special sports edition. Shrouds of AS Silence: Star athletes open about PCa treatment, but secretive about Active Surveillance? , by @journotwit https://t.co/Rg0XE5RGqZ
Good news for AS from a couple of big names in health care: Diet and lifestyle can slow or even halt low-risk prostate cancer and more, by @journotwit https://t.co/KzOdC5u3b8 1
Good news for AS from a couple of big names in health care: Diet and lifestyle can slow or even halt low-risk prostate cancer and more, by @journotwit https://t.co/KzOdC5u3b8